Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 10 October, 2025
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 500039 | NSE: BANCOINDIA

Banco Products (India) Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 10, 2025, 8:18 pm

Market Cap 11,506 Cr.
Current Price 804
High / Low 880/293
Stock P/E26.6
Book Value 91.1
Dividend Yield1.37 %
ROCE32.4 %
ROE32.2 %
Face Value 2.00
PEG Ratio1.15

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Banco Products (India) Ltd

Competitors of Banco Products (India) Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
IP Rings Ltd 184 Cr. 145 240/108 80.00.00 %3.08 %4.14 % 10.0
Talbros Automotive Components Ltd 1,804 Cr. 292 353/20018.8 1020.24 %19.3 %15.9 % 2.00
Sundram Fasteners Ltd 21,036 Cr. 1,001 1,498/83138.6 1810.72 %17.1 %14.9 % 1.00
Sintercom India Ltd 341 Cr. 124 186/110401 36.90.00 %5.08 %0.66 % 10.0
Shriram Pistons & Rings Ltd 11,774 Cr. 2,672 2,790/1,55622.4 5430.37 %25.7 %23.2 % 10.0
Industry Average13,786.50 Cr3,746.3064.95538.220.60%16.53%14.30%7.25

All Competitor Stocks of Banco Products (India) Ltd

Quarterly Result

MetricJun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
Sales 586628509609749725571724804895639875970
Expenses 519569369511653602482610671689581660788
Operating Profit 675914098971228911413320658214182
OPM % 11%9%28%16%13%17%16%16%17%23%9%24%19%
Other Income 1101316312621751914
Interest 2137564776587
Depreciation 12121320151617281919203624
Profit before tax 55561267493104818610919739190164
Tax % 37%8%22%31%26%36%15%20%37%30%21%19%33%
Net Profit 35529851696668686913931154110
EPS in Rs 2.423.626.873.574.814.624.784.774.809.702.1610.737.66

Last Updated: August 20, 2025, 1:05 pm

Below is a detailed analysis of the quarterly data for Banco Products (India) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

  • For Sales, as of Jun 2025, the value is 970.00 Cr.. The value appears strong and on an upward trend. It has increased from 875.00 Cr. (Mar 2025) to 970.00 Cr., marking an increase of 95.00 Cr..
  • For Expenses, as of Jun 2025, the value is 788.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 660.00 Cr. (Mar 2025) to 788.00 Cr., marking an increase of 128.00 Cr..
  • For Operating Profit, as of Jun 2025, the value is 182.00 Cr.. The value appears to be declining and may need further review. It has decreased from 214.00 Cr. (Mar 2025) to 182.00 Cr., marking a decrease of 32.00 Cr..
  • For OPM %, as of Jun 2025, the value is 19.00%. The value appears to be declining and may need further review. It has decreased from 24.00% (Mar 2025) to 19.00%, marking a decrease of 5.00%.
  • For Other Income, as of Jun 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 19.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 5.00 Cr..
  • For Interest, as of Jun 2025, the value is 7.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8.00 Cr. (Mar 2025) to 7.00 Cr., marking a decrease of 1.00 Cr..
  • For Depreciation, as of Jun 2025, the value is 24.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 36.00 Cr. (Mar 2025) to 24.00 Cr., marking a decrease of 12.00 Cr..
  • For Profit before tax, as of Jun 2025, the value is 164.00 Cr.. The value appears to be declining and may need further review. It has decreased from 190.00 Cr. (Mar 2025) to 164.00 Cr., marking a decrease of 26.00 Cr..
  • For Tax %, as of Jun 2025, the value is 33.00%. The value appears to be increasing, which may not be favorable. It has increased from 19.00% (Mar 2025) to 33.00%, marking an increase of 14.00%.
  • For Net Profit, as of Jun 2025, the value is 110.00 Cr.. The value appears to be declining and may need further review. It has decreased from 154.00 Cr. (Mar 2025) to 110.00 Cr., marking a decrease of 44.00 Cr..
  • For EPS in Rs, as of Jun 2025, the value is 7.66. The value appears to be declining and may need further review. It has decreased from 10.73 (Mar 2025) to 7.66, marking a decrease of 3.07.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 5:27 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 1,1161,1291,1481,2391,3361,5671,4221,5331,9582,3322,7683,2133,379
Expenses 9511,0271,0021,0961,1571,4051,3001,3541,6861,9662,3402,6012,718
Operating Profit 165102146144179161122178272366428611660
OPM % 15%9%13%12%13%10%9%12%14%16%15%19%20%
Other Income 95311321810259514324355
Interest 198322434513212626
Depreciation 32343533282933344856769499
Profit before tax 122113119141167138111150224311363534590
Tax % 26%22%25%31%30%50%31%24%32%24%25%27%
Net Profit 908890971176977114152236271392433
EPS in Rs 6.286.136.296.808.174.835.367.9510.6616.4718.9827.3930.25
Dividend Payout % 16%24%37%66%61%83%187%13%94%67%53%40%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-2.22%2.27%7.78%20.62%-41.03%11.59%48.05%33.33%55.26%14.83%44.65%
Change in YoY Net Profit Growth (%)0.00%4.49%5.51%12.84%-61.64%52.62%36.46%-14.72%21.93%-40.43%29.82%

Banco Products (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:11%
5 Years:18%
3 Years:18%
TTM:20%
Compounded Profit Growth
10 Years:20%
5 Years:39%
3 Years:36%
TTM:60%
Stock Price CAGR
10 Years:27%
5 Years:67%
3 Years:68%
1 Year:80%
Return on Equity
10 Years:19%
5 Years:24%
3 Years:28%
Last Year:32%

Last Updated: September 5, 2025, 12:30 am

Balance Sheet

Last Updated: September 10, 2025, 1:32 pm

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital 141414141414141414141429
Reserves 5746056747057938186968149679871,0371,274
Borrowings 17236363834409214115418423573
Other Liabilities 183164232211356322287344405435508868
Total Liabilities 9448199569691,1971,1951,0891,1871,5021,8551,9822,744
Fixed Assets 243227221192191184193190297359454516
CWIP 1211341313311518105
Investments 71119124699110038
Other Assets 6185817316829699298839951,1901,4771,5182,185
Total Assets 9448199569691,1971,1951,0891,1871,5021,8551,9822,744

Below is a detailed analysis of the balance sheet data for Banco Products (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Mar 2025, the value is 29.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Mar 2024) to 29.00 Cr., marking an increase of 15.00 Cr..
  • For Reserves, as of Mar 2025, the value is 1,274.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,037.00 Cr. (Mar 2024) to 1,274.00 Cr., marking an increase of 237.00 Cr..
  • For Borrowings, as of Mar 2025, the value is 573.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 423.00 Cr. (Mar 2024) to 573.00 Cr., marking an increase of 150.00 Cr..
  • For Other Liabilities, as of Mar 2025, the value is 868.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 508.00 Cr. (Mar 2024) to 868.00 Cr., marking an increase of 360.00 Cr..
  • For Total Liabilities, as of Mar 2025, the value is 2,744.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,982.00 Cr. (Mar 2024) to 2,744.00 Cr., marking an increase of 762.00 Cr..
  • For Fixed Assets, as of Mar 2025, the value is 516.00 Cr.. The value appears strong and on an upward trend. It has increased from 454.00 Cr. (Mar 2024) to 516.00 Cr., marking an increase of 62.00 Cr..
  • For CWIP, as of Mar 2025, the value is 5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10.00 Cr. (Mar 2024) to 5.00 Cr., marking a decrease of 5.00 Cr..
  • For Investments, as of Mar 2025, the value is 38.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 38.00 Cr., marking an increase of 38.00 Cr..
  • For Other Assets, as of Mar 2025, the value is 2,185.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,518.00 Cr. (Mar 2024) to 2,185.00 Cr., marking an increase of 667.00 Cr..
  • For Total Assets, as of Mar 2025, the value is 2,744.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,982.00 Cr. (Mar 2024) to 2,744.00 Cr., marking an increase of 762.00 Cr..

Notably, the Reserves (1,274.00 Cr.) exceed the Borrowings (573.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow - No data available for this post.

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-7.0066.00110.00106.00145.00121.0030.00164.00157.00-52.005.0038.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days705770607063756460656369
Inventory Days172152190171217191212234225271210289
Days Payable573971519010299118959590128
Cash Conversion Cycle184170189180197152188180191241183231
Working Capital Days71103107105108111120132133123102106
ROCE %19%12%18%17%21%17%13%19%24%26%27%32%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
Promoters67.88%67.88%67.88%67.88%67.88%67.88%67.88%67.88%67.88%67.88%67.88%67.88%
FIIs0.74%1.15%1.88%1.87%2.07%2.35%3.00%3.21%3.08%3.76%3.88%3.83%
DIIs0.02%0.02%0.03%0.02%0.02%0.08%0.13%0.14%0.18%0.21%0.17%0.43%
Public31.37%30.95%30.20%30.23%30.04%29.69%28.97%28.77%28.86%28.15%28.07%27.85%
No. of Shareholders43,25743,18040,57140,55048,39947,75151,17252,82358,79560,52767,94569,540

Shareholding Pattern Chart

No. of Shareholders

Banco Products (India) Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 2.002.002.002.002.00
Basic EPS (Rs.) 37.9532.9421.3115.9010.71
Diluted EPS (Rs.) 37.9532.9421.3115.9010.71
Cash EPS (Rs.) 48.5740.8228.0020.6115.29
Book Value[Excl.RevalReserv]/Share (Rs.) 146.95139.96137.19115.7699.20
Book Value[Incl.RevalReserv]/Share (Rs.) 147.03140.03137.27115.8399.28
Revenue From Operations / Share (Rs.) 387.09326.04273.78214.29198.84
PBDIT / Share (Rs.) 64.3353.1038.7226.1720.60
PBIT / Share (Rs.) 53.7045.2232.0221.4616.02
PBT / Share (Rs.) 50.7143.4631.2920.9515.59
Net Profit / Share (Rs.) 37.9532.9421.3115.9010.71
NP After MI And SOA / Share (Rs.) 37.9532.9421.3115.9010.71
PBDIT Margin (%) 16.6116.2814.1412.2110.36
PBIT Margin (%) 13.8713.8611.6910.018.05
PBT Margin (%) 13.1013.3211.429.777.83
Net Profit Margin (%) 9.8010.107.787.425.38
NP After MI And SOA Margin (%) 9.8010.107.787.425.38
Return on Networth / Equity (%) 25.8223.5315.5313.7310.79
Return on Capital Employeed (%) 28.3226.2119.6316.8914.40
Return On Assets (%) 13.3812.509.959.356.87
Long Term Debt / Equity (X) 0.030.030.010.010.01
Total Debt / Equity (X) 0.210.290.020.010.12
Asset Turnover Ratio (%) 1.420.840.790.700.65
Current Ratio (X) 2.242.243.173.212.70
Quick Ratio (X) 0.860.701.201.371.20
Inventory Turnover Ratio (X) 1.591.311.391.211.23
Dividend Payout Ratio (NP) (%) 89.5924.289.380.00214.80
Dividend Payout Ratio (CP) (%) 69.9919.597.140.00150.43
Earning Retention Ratio (%) 10.4175.7290.620.00-114.80
Cash Earning Retention Ratio (%) 30.0180.4192.860.00-50.43
Interest Coverage Ratio (X) 21.5430.1852.6951.7347.59
Interest Coverage Ratio (Post Tax) (X) 13.7019.7230.0032.4425.73
Enterprise Value (Cr.) 4411.671882.76913.42896.66486.31
EV / Net Operating Revenue (X) 1.590.800.460.580.34
EV / EBITDA (X) 9.594.963.304.793.30
MarketCap / Net Operating Revenue (X) 1.540.690.490.650.32
Retention Ratios (%) 10.4075.7190.610.00-114.80
Price / BV (X) 4.051.610.991.210.65
Price / Net Operating Revenue (X) 1.540.690.490.650.32
EarningsYield 0.060.140.150.110.16

After reviewing the key financial ratios for Banco Products (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 37.95. This value is within the healthy range. It has increased from 32.94 (Mar 23) to 37.95, marking an increase of 5.01.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 37.95. This value is within the healthy range. It has increased from 32.94 (Mar 23) to 37.95, marking an increase of 5.01.
  • For Cash EPS (Rs.), as of Mar 24, the value is 48.57. This value is within the healthy range. It has increased from 40.82 (Mar 23) to 48.57, marking an increase of 7.75.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 146.95. It has increased from 139.96 (Mar 23) to 146.95, marking an increase of 6.99.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 147.03. It has increased from 140.03 (Mar 23) to 147.03, marking an increase of 7.00.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 387.09. It has increased from 326.04 (Mar 23) to 387.09, marking an increase of 61.05.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 64.33. This value is within the healthy range. It has increased from 53.10 (Mar 23) to 64.33, marking an increase of 11.23.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 53.70. This value is within the healthy range. It has increased from 45.22 (Mar 23) to 53.70, marking an increase of 8.48.
  • For PBT / Share (Rs.), as of Mar 24, the value is 50.71. This value is within the healthy range. It has increased from 43.46 (Mar 23) to 50.71, marking an increase of 7.25.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 37.95. This value is within the healthy range. It has increased from 32.94 (Mar 23) to 37.95, marking an increase of 5.01.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 37.95. This value is within the healthy range. It has increased from 32.94 (Mar 23) to 37.95, marking an increase of 5.01.
  • For PBDIT Margin (%), as of Mar 24, the value is 16.61. This value is within the healthy range. It has increased from 16.28 (Mar 23) to 16.61, marking an increase of 0.33.
  • For PBIT Margin (%), as of Mar 24, the value is 13.87. This value is within the healthy range. It has increased from 13.86 (Mar 23) to 13.87, marking an increase of 0.01.
  • For PBT Margin (%), as of Mar 24, the value is 13.10. This value is within the healthy range. It has decreased from 13.32 (Mar 23) to 13.10, marking a decrease of 0.22.
  • For Net Profit Margin (%), as of Mar 24, the value is 9.80. This value is within the healthy range. It has decreased from 10.10 (Mar 23) to 9.80, marking a decrease of 0.30.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.80. This value is within the healthy range. It has decreased from 10.10 (Mar 23) to 9.80, marking a decrease of 0.30.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 25.82. This value is within the healthy range. It has increased from 23.53 (Mar 23) to 25.82, marking an increase of 2.29.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 28.32. This value is within the healthy range. It has increased from 26.21 (Mar 23) to 28.32, marking an increase of 2.11.
  • For Return On Assets (%), as of Mar 24, the value is 13.38. This value is within the healthy range. It has increased from 12.50 (Mar 23) to 13.38, marking an increase of 0.88.
  • For Long Term Debt / Equity (X), as of Mar 24, the value is 0.03. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.03.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.21. This value is within the healthy range. It has decreased from 0.29 (Mar 23) to 0.21, marking a decrease of 0.08.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 1.42. It has increased from 0.84 (Mar 23) to 1.42, marking an increase of 0.58.
  • For Current Ratio (X), as of Mar 24, the value is 2.24. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.24.
  • For Quick Ratio (X), as of Mar 24, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.70 (Mar 23) to 0.86, marking an increase of 0.16.
  • For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.59. This value is below the healthy minimum of 4. It has increased from 1.31 (Mar 23) to 1.59, marking an increase of 0.28.
  • For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 89.59. This value exceeds the healthy maximum of 50. It has increased from 24.28 (Mar 23) to 89.59, marking an increase of 65.31.
  • For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 69.99. This value exceeds the healthy maximum of 50. It has increased from 19.59 (Mar 23) to 69.99, marking an increase of 50.40.
  • For Earning Retention Ratio (%), as of Mar 24, the value is 10.41. This value is below the healthy minimum of 40. It has decreased from 75.72 (Mar 23) to 10.41, marking a decrease of 65.31.
  • For Cash Earning Retention Ratio (%), as of Mar 24, the value is 30.01. This value is below the healthy minimum of 40. It has decreased from 80.41 (Mar 23) to 30.01, marking a decrease of 50.40.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 21.54. This value is within the healthy range. It has decreased from 30.18 (Mar 23) to 21.54, marking a decrease of 8.64.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 13.70. This value is within the healthy range. It has decreased from 19.72 (Mar 23) to 13.70, marking a decrease of 6.02.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 4,411.67. It has increased from 1,882.76 (Mar 23) to 4,411.67, marking an increase of 2,528.91.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.59. This value is within the healthy range. It has increased from 0.80 (Mar 23) to 1.59, marking an increase of 0.79.
  • For EV / EBITDA (X), as of Mar 24, the value is 9.59. This value is within the healthy range. It has increased from 4.96 (Mar 23) to 9.59, marking an increase of 4.63.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.54. This value is within the healthy range. It has increased from 0.69 (Mar 23) to 1.54, marking an increase of 0.85.
  • For Retention Ratios (%), as of Mar 24, the value is 10.40. This value is below the healthy minimum of 30. It has decreased from 75.71 (Mar 23) to 10.40, marking a decrease of 65.31.
  • For Price / BV (X), as of Mar 24, the value is 4.05. This value exceeds the healthy maximum of 3. It has increased from 1.61 (Mar 23) to 4.05, marking an increase of 2.44.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.54. This value is within the healthy range. It has increased from 0.69 (Mar 23) to 1.54, marking an increase of 0.85.
  • For EarningsYield, as of Mar 24, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.14 (Mar 23) to 0.06, marking a decrease of 0.08.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Banco Products (India) Ltd as of October 10, 2025 is: 632.78

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of October 10, 2025, Banco Products (India) Ltd is Overvalued by 21.30% compared to the current share price 804.00

Intrinsic Value of Banco Products (India) Ltd as of October 10, 2025 is: 779.55

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of October 10, 2025, Banco Products (India) Ltd is Overvalued by 3.04% compared to the current share price 804.00

Last 5 Year EPS CAGR: 23.20%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 20.42%, which is a positive sign.
  2. The company has higher reserves (828.67 cr) compared to borrowings (165.92 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (1.46 cr) and profit (237.15 cr) over the years.
  1. The stock has a high average Working Capital Days of 110.08, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 190.50, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Banco Products (India) Ltd:
    1. Net Profit Margin: 9.8%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 28.32% (Industry Average ROCE: 16.53%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 25.82% (Industry Average ROE: 14.3%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 13.7
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.86
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 26.6 (Industry average Stock P/E: 59.54)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.21
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Banco Products (India) Ltd. is a Public Limited Listed company incorporated on 16/03/1961 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L51100GJ1961PLC001039 and registration number is 001039. Currently Company is involved in the business activities of Manufacture of diverse parts and accessories for motor vehecles sucs as brakes, gearboxes, axles, road wheels, suspension shock absorbers, radiators, silencers, exhaust pipes, catalysers, clutches, steering wheels, steering columns and steering boxes etc.. Company's Total Operating Revenue is Rs. 1104.99 Cr. and Equity Capital is Rs. 28.61 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Auto Ancl - Engine PartsBil, Near Bhaili Railway Station, Vadodra District Gujarat 391410investor@bancoindia.com
http://www.bancoindia.com
Management
NamePosition Held
Mr. Mehul K PatelChairman
Mr. Venkata Ranganath Kumar SamiWhole Time Director
Mr. Sharan M PatelWhole Time Director
Mr. Shivam M PatelNon Executive Director
Ms. Ameeta V ManoharIndependent Director
Mr. Tarak A PatelIndependent Director
Mr. Anand A MajmudarIndependent Director
Mr. Pranav R PatelIndependent Director

FAQ

What is the intrinsic value of Banco Products (India) Ltd?

Banco Products (India) Ltd's intrinsic value (as of 10 October 2025) is 632.78 which is 21.30% lower the current market price of 804.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹11,506 Cr. market cap, FY2025-2026 high/low of 880/293, reserves of ₹1,274 Cr, and liabilities of 2,744 Cr.

What is the Market Cap of Banco Products (India) Ltd?

The Market Cap of Banco Products (India) Ltd is 11,506 Cr..

What is the current Stock Price of Banco Products (India) Ltd as on 10 October 2025?

The current stock price of Banco Products (India) Ltd as on 10 October 2025 is 804.

What is the High / Low of Banco Products (India) Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Banco Products (India) Ltd stocks is 880/293.

What is the Stock P/E of Banco Products (India) Ltd?

The Stock P/E of Banco Products (India) Ltd is 26.6.

What is the Book Value of Banco Products (India) Ltd?

The Book Value of Banco Products (India) Ltd is 91.1.

What is the Dividend Yield of Banco Products (India) Ltd?

The Dividend Yield of Banco Products (India) Ltd is 1.37 %.

What is the ROCE of Banco Products (India) Ltd?

The ROCE of Banco Products (India) Ltd is 32.4 %.

What is the ROE of Banco Products (India) Ltd?

The ROE of Banco Products (India) Ltd is 32.2 %.

What is the Face Value of Banco Products (India) Ltd?

The Face Value of Banco Products (India) Ltd is 2.00.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Banco Products (India) Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore More Stocks